Pfizer Paxlovid
-
U.S. doctors reconsider use of Pfizer’s COVID-19 pill for lower-risk patientsPaxlovid's emergency authorization stipulates that it should be used only for newly infected people with risk factors, but doctors said many others have sought out a prescription.HealthMay 28
-
Generic versions of Pfizer’s Paxlovid to be sold in low-income countries for $25 or lessA generic course of molnupiravir is expected to cost about $20 in poorer nations, compared with the roughly $700 per course Merck is charging the United States.HealthMay 12
-
Some report COVID symptoms after taking Pfizer’s Paxlovid. Here’s what we knowAs Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment and experiencing improvement.HealthMay 11
![]()
-
Paxlovid ‘inaccessible’ to many patients in Canada. Here’s why that needs to changeWith COVID-19 infections surging across Canada, experts say the patchwork distribution system for Paxlovid throughout the country may inhibit those who most need the drug.CanadaApr 13
![]()
